Data from The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and TP53-Mutant AML
Authors:
- Bing Z. CarterBCBing Z. Carter
- Po Yee MakPMPo Yee Mak
- Suresh SatpatiSSSuresh Satpati
- Edward AyoubEAEdward Ayoub
- Steffen BoettcherSBSteffen Boettcher
- Lauren B. OstermannLOLauren B. Ostermann
- Yue WeiYWYue Wei
- Guillermo Garcia-ManeroGGGuillermo Garcia-Manero
- Torsten HaferlachTHTorsten Haferlach
- Kunal RaiKRKunal Rai
- Michael AndreeffMAMichael Andreeff
Open Access
- 15 September 2026
- other
- Published by American Association for Cancer Research (AACR)